Back to results
US 5,478,848 AGranted
Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
AssigneeBayer Aktiengesellschaft
InventorThomas M. Aune
Life of this patent
Estimating the term…
Abstract
The present invention comprises new methods for treating rheumatoid arthritis. It has been found that the L-type calcium channel antagonists are effective in treating arthritis. Nimodipine, nisoldipine, and nifedipine, are examples of specific compounds useful in the present invention.
Claims8
A method of treating rheumatoid arthritis in mammals comprising administering a therapeutically effective amount of a dihydropyridine L-type calcium channel antagonist selected from the group consisting of nimodipine, nisoldipine, nifedipine, and mixtures thereof.
Dependencies are inferred from the claim text.